Nuclear Imaging Equipment Market Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2026

Nuclear imaging involves examining various organs and tissue structures and functions. It involves use of small doses of radioactive materials called as radiotracers, which are introduced in the bloodstream. The body structure under examination is inspected as radiotracer travels through the area or gathers together in the area to offer reading in the form of gamma rays. These gamma rays are identified by a device (specifically developed to read gamma rays) and the rays are projected on a digital system. Several diseases such as cancer and cardiovascular diseases can be identified in their earliest stages due to the unique information obtained by nuclear medicine imaging, which otherwise is challenging to obtain using other imaging procedures. Except intravenous injections, all other route of administrations used for nuclear medicine imaging are noninvasive.

The global nuclear imaging equipment market size was valued at US$ 2,220.5 million in 2017 and is expected to exhibit a CAGR of 4.4% over the forecast period (2018 – 2026).

Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2366

Market Dynamics:

Increasing adoption of nuclear imaging equipment in healthcare settings is attributed to benefits of nuclear imaging equipment in improving selection therapy and monitoring patient response for a specific treatment. Furthermore, Medicare and private insurance companies cover the cost of various nuclear imaging procedures, thereby increasing the adoption rate of the equipment in emerging economies. Increasing prevalence of cardiovascular diseases also propels demand for nuclear imaging. Cardiovascular diseases require diagnostic tests to identify heart disease, severity of prior heart attacks, and the risk of future heart attacks. According to a report by the Centers for Disease Control and Prevention (CDC), 2015, around 800,000 people in the U.S. die due to stroke and other cardiovascular diseases.

The global nuclear imaging equipment market is expected to be driven by increasing prevalence of chronic diseases including cardiac diseases and cancer

Increasing prevalence of chronic diseases is expected to propel growth of the nuclear imaging equipment market. According to a report published by Center for Chronic Disease Prevention and Health Promotion 2012, around 117 million people were suffering from at least one chronic health condition and one in four adults had two or more chronic health conditions in the U.S. Moreover, according World Health Organization (WHO), chronic diseases are expected to account for around three-quarters of all deaths worldwide by 2020. WHO further stated that around 71% of these deaths would occur due to Ischaemic Heart Disease (IHD) and 75% due to stroke.

Increasing funding for development of advanced nuclear imaging equipment is expected to propel the market growth. For instance, the National Institute of Biomedical Imaging and Bioengineering is focusing on offering funding to develop new radio tracers and technologies in order to enhance image quality of nuclear imaging equipment. Moreover, in November 2018, the Radiological Society of North America (RSNA) Research & Education (R&E) Foundation granted US$ 40,000 for its joint research grants with Canon Medical Systems.

Key Players:

Key players in the global nuclear imaging equipment market are focused on new product launch to enhance their market share. For instance, in May 2018, the Food and Drug Administration (FDA) cleared— Biograph Vision— a positron emission tomography/computed tomography system developed by Siemens Healthineers. The system helps to reduce scan time to improve patient throughput and also reduces patient radiation exposure and tracer cost.

Major players operating in the global nuclear imaging equipment market include,

• Siemens Healthineers
• Koninklijke Philips N.V.
• GE Healthcare
• Toshiba Medical Systems Corporation
• Neusoft Medical Systems Co., Ltd.
• Mediso Medical Imaging Systems Co., Ltd.
• CMR Naviscan Corporation
• Digirad Corporation
• SurgiEye GmbH
• Positron Corporation

Detailed Segmentation:

Global Nuclear Imaging Equipment Market, By Product Type:
• Single-Photon Emission Computed Tomography (SPECT) Systems
• Hybrid SPECT
• Standalone SPECT
• Hybrid Positron Emission Tomography (PET) Systems
• Planar Scintigraphy

Global Nuclear Imaging Equipment Market, By Application:
• Oncology
• Cardiology
• Neurology
• Others

Global Nuclear Imaging Equipment Market, By End User:
• Hospitals
• Imaging Centers
• Research Institutes
• Others

Global Nuclear Imaging Equipment Market, By Geography:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2366

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.